Treatment for HIV Infections

Phase-Based Progress Estimates
Alzheimers Disease Research Ctr 0948 / UCSD, San Diego, CA
HIV Infections
All Sexes
What conditions do you have?

Study Summary

This study is evaluating whether a drug called CPI-1189 might be able to prevent or slow down the progression of AIDS dementia.

See full description

Treatment Effectiveness

Effectiveness Progress

1 of 3

Other trials for HIV Infections

Trial Safety

Safety Progress

2 of 3
This is further along than 68% of similar trials

Other trials for HIV Infections

Trial Design

0 Treatment Group

This trial requires 60 total participants across 0 different treatment group

Trial Logistics

Trial Timeline

Approximate Timeline
Screening: ~3 weeks
Treatment: Varies
Reporting: up to 5 years
This trial has the following approximate timeline: 3 weeks for initial screening, variable treatment timelines, and roughly up to 5 years for reporting.

Closest Location

Alzheimers Disease Research Ctr 0948 / UCSD - San Diego, CA

Eligibility Criteria

This trial is for patients born any sex aged 18 and older. There are 4 eligibility criteria to participate in this trial as listed below.

Mark “yes” if the following statements are true for you:
Are HIV-positive.
Are at least 18 years old.
Have symptoms of AIDS dementia including forgetfulness, loss of concentration, slow mental processing, or a loss of muscle control.
Have been on stable anti-HIV drug therapy for the past 6 weeks (if you are taking anti-HIV drugs).

Patient Q&A Section

Ask a question about the study

Other questions from users

Please Note: These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.

Are there any geographic restrictions to consider when applying for this trial?

Patients from any state can participate in this trial, so long as they are able to attend all treatment sessions.

Will my insurance cover participating in this trial?

In order to understand how insurance coverage works for this trial, you will need to contact the study coordinator.

See if you qualify for this trial
Get access to this novel treatment for HIV Infections by sharing your contact details with the study coordinator.